see full chart & Follow at tradingview.com/u/WallSt007
We caught the reversal last week, Very strong reversal based on some good news.
we sold our position at $13.90, but if your still in, next level is probably $15.90 area.
that will be a tough level to break.
CODX
Entry $14
stoploss $13
target $16
What is CODX??
Co-Diagnostics, Inc. engages in the development, manufacture, and marketing of diagnostics technology. It offers design services, vector control, equipment, diagnostic, and research solutions. The company was founded by Brent C. Satterfield and Dwight H. Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.
We caught the reversal last week, Very strong reversal based on some good news.
we sold our position at $13.90, but if your still in, next level is probably $15.90 area.
that will be a tough level to break.
CODX
Entry $14
stoploss $13
target $16
What is CODX??
Co-Diagnostics, Inc. engages in the development, manufacture, and marketing of diagnostics technology. It offers design services, vector control, equipment, diagnostic, and research solutions. The company was founded by Brent C. Satterfield and Dwight H. Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.
If you appreciate my technical analysis and want to check out our
Free Newsletter --> diywallst.substack.com/about
VX algo Discord--> whop.com/diywallst/
Promo Code Diywallst
Free Newsletter --> diywallst.substack.com/about
VX algo Discord--> whop.com/diywallst/
Promo Code Diywallst
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
If you appreciate my technical analysis and want to check out our
Free Newsletter --> diywallst.substack.com/about
VX algo Discord--> whop.com/diywallst/
Promo Code Diywallst
Free Newsletter --> diywallst.substack.com/about
VX algo Discord--> whop.com/diywallst/
Promo Code Diywallst
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.